No results found

Check the spelling or try searching for a more general term.

Laser Floater Treatment

Laser Floater Treatment

Transform visual functionality, improve patients' life quality

While floaters can be overlooked as a common symptom of vitreous deterioration, the adverse effect that they can have on a patient’s quality of life is sometimes significant enough to warrant treatment. A study of over 300 outpatients reported that floaters had the same negative impact on quality of life as age-related macular degeneration*.

Related products

Related conditions

Main Image Lft
Image courtesy of Karl Brasse, MD, MRCOphth

Watch how LFT (Laser Floater Treatment) with Reflex™ Technology can safely and effectively alleviate the debilitating effects of persistent vitreous opacities, or floaters.

WATCH THE LFT ANIMATION

Floaters. Visualize and Vaporize. 

Performed with Reflex™ Technology from Ellex, Laser Floater Treatment or LFT is a minimally invasive procedure that can significantly improve a patient's perception of their everyday visual functionality and provide them with much-needed relief from eye floaters. The technique fills the treatment gap for patients whose symptoms and risk profile does not warrant treatment with vitrectomy. Laser Floater Treatment can also delay or obviate the need for surgery.

  • Offers a treatment alternative for suitable patients whose profile does not warrant vitrectomy
  • Unique system delivering improved visualization and treatment efficacy
  • Deploys Reflex™ Technology designed specifically for treating floaters

1 (Wagle AM, Lim WY, Yap TP, et al. Utility values associated with vitreous floaters. Am J Ophthalmol. 2011;152(1):60-65.)

    Accurate, effective treatment

    Ellex was the first company to pioneer a laser designed specifically for the treatment of floaters. Our Reflex™ Technology features True Coaxial Illumination™ (TCI) for on- and off-axis visualization, a precise aiming beam and a superior energy beam profile — all within a unique slit lamp illumination tower design that converges and focuses the physician’s sight line, target illumination and treatment beam into one optical path.

    It’s an approach that maximizes focusing accuracy and provides a safe and highly effective tool for the treatment of vitreous opacities.

    Full visualization from the cornea to the retina

    With proprietary Reflex™ Technology, visualizing floaters and opacities, and assessing their position relative to the lens or retina, has never been easier. True Coaxial Illumination provides a full view from the cornea to the retina along with much-needed spatial context.

    Treat with greater accuracy 

    Reflex™ Technology allows you to move effortlessly between on-axis and off-axis viewing and provides the highest levels of visualization accuracy and illumination in the anterior and posterior segments, all from one platform.

    Lower energy treatments 

    Reflex™ Technology provides higher-power density and precisely controlled plasma formation – the end result is that fewer shots are required to perform treatment with less cumulative energy delivered.

    No missed shots, shorter treatment times

    One of the challenges with LFT or Laser Floater Treatment is that the high number of shots required can cause the laser cavity to overheat. Reflex™ Technology utilizes a unique method of “Active Cooling” which circulates air throughout the laser cavity to ensure constant cooling, thereby ensuring that the laser works without interruption.

    Prevent post-capsulotomy floaters

    The benefits of True Coaxial Illumination™ extend beyond safe treatment of floaters, and in fact help to prevent the notoriously common patient complaint of sudden floater development after capsulotomy.

    “We have been programmed to minimize the impact of floaters on patient’s daily lives because we had no viable solution. Today we have a solution.”
    Singh
    “I adopted Laser Floater Treatment just over three years ago. More than 3,000 procedures later, I now fully appreciate the negative impact that symptomatic floaters can have on patients’ quality of life. When looking at the results in my own clinic, more than 90% of patients indicate that they are satisfied with their improvement in daily visual functioning as a result of undergoing the procedure.”
    Singh
    “Modern laser floater treatment is a different procedure. It is not the same procedure as in past years. Earlier attempts at treating floaters were not always positive, because the technology was not optimized for the procedure.”
    BRASSE QUOTE
    “When it comes to the treatment of floaters, precise spatial context is critical. To achieve this, both off-axis and on-axis illumination is required. This ensures that when a surgeon looks into an eye, he or she can clearly establish where the lens, floater and retina lie in relation to the floater and to each other.”
    Singh

    Resources

    Case Study

    LFT Clinical Evidence

    Published in JAMA Ophthalmology, this trial by Chirag P. Shah, MD and Jeffrey S. Heler, MD evaluates the efficacy of YAG laser vitreolysis vs. sham vitreolysis for symptomatic Weiss ring floaters from posterior vitreous detachment, featuring the proprietary Reflex Technology platform.

    Article

    Laser Vitreolysis for Floaters

    In this article, Karl Stonecipher, MD (USA) provides his treatment pearls for LFT in clinical practice.

    Article

    Roundtable Discussion, LFT

    “The Evolving View of Laser Vitreolysis” In this roundtable discussion, ophthalmologists working in glaucoma, retina, cataract and refractive surgery talked with Inder Paul Singh, MD, about prospective clinical study data, hands-on experiences, and how their profession’s view of LFT is evolving alongside growing data and the introduction of the new Reflex Technology platform.

    Article

    Laser Vitreolysis: A Retinal Specialist's Viewpoint

    In this supplement to Retina Today, Chirag P. Shah, MD, MPH addresses his pivotal trial into the safety and efficacy of laser vitreolysis.

    Associated websites

    Floater Patient Education

    A simple in-office procedure, LFT can help to alleviate the visual disturbance caused by floaters.

    Video

    Titratable Illumination with Reflex technology™

    Dr. Paul Singh (USA) demonstrates the use of titratable illumination to view floaters that are within the posterior capsule clearly – whilst also viewing the retina.

    Video

    Laser Floater Treatment Through a Multi-Focal Lens

    In this video, Paul I. Singh, MD (USA) uses the Ultra Q Reflex™ laser to perform Laser Floater Treatment in a patient with a multi-focal lens.

    Video

    Laser Floater Treatment – Paul Inder Singh, MD

    In this video interview, Paul I. Singh, MD (USA) addresses the clinical impact of floaters and the success of Laser Floater Treatment in his practice.

    Video

    Floaters and the Refractive Surgeon – Karl G. Stonecipher, MD

    In this video interview, refractive specialist Karl G. Stonecipher, MD (USA) addresses his decision to incorporate Laser Floater Treatment into clinical practice.

    Video

    Modern Laser Vitreolysis - Karl Brasse, MD

    Compared with its early clinical use in the 1980s, modern laser vitreolysis provides more efficient and safer energy profiles, offering reliable and repeatable outcomes that provide a low rate of complications combined with a high degree of patient satisfaction.

    Contact us

    Ellex is the manufacturer of Reflex Technology for use in the treatment of symptomatic floater patients. It has been approved for the indication of Posterior Membranectomy (incl. Nd:YAG Laser Vitreolysis/Laser Floater Treatment) whereby it offers the potential to improve the patient’s perception of visual functionality. Ellex does not accept any responsibility for use of the system outside of these indications. The material presented herein may include the views or recommendations of third parties and does not necessarily reflect the views of Ellex Medical Pty Ltd.

    Ultra Q Reflex™ has a CE Mark (Conformité Européenne) and US Food and Drug Administration (FDA) (510k) Market release for the treatment Posterior Membranectomy, Capsulotomy and Laser Iridotomy.

    This website uses cookies to ensure you get the best experience on our website.
    The cookies do not store any personalised information. Learn More